Shiow-Lin Pan

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Protein science : a publication of the Protein Society

Journal of enzyme inhibition and medicinal chemistry

Cell & bioscience

Oncogenesis

Taipei Medical University

National Taiwan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Taipei Medical University Feb 01 2013

Taiwan

Professor :: Ph.D. Program for Cancer Molecular Biology and Drug Discovery

National Health Research Institutes Dec 01 2009 - Jan 31 2013

Taiwan

Assistant Investigator :: Institute of Biotechnology and Pharmaceutical Research

Education History

National Taiwan University Aug 01 1998 - Jul 31 2002

Taiwan

PHD :: Pharmacological Institute, College of Medicine

Publications

Cheng-Chiao Huang, Chia-Ming Hsu, Min-Wu Chao, Kai-Cheng Hsu, Tony Eight Lin, Shih-Chung Yen, Huang-Ju Tu, Shiow-Lin Pan
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer. Protein science : a publication of the Protein Society 33 (6) (2024)
Tony Eight Lin, Dyan Yen, Wei-Chun HuangFu, Yi-Wen Wu, Jui-Yi Hsu, Shih-Chung Yen, Tzu-Ying Sung, Jui-Hua Hsieh, Shiow-Lin Pan, Chia-Ron Yang, Wei-Jan Huang, Kai-Cheng Hsu
An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors. Protein science : a publication of the Protein Society 33 (6) (2024)
Tony Eight Lin, Dyan Yen, Wei-Chun HuangFu, Yi-Wen Wu, Jui-Yi Hsu, Shih-Chung Yen, Tzu-Ying Sung, Jui-Hua Hsieh, Shiow-Lin Pan, Chia-Ron Yang, Wei-Jan Huang, Kai-Cheng Hsu
An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors. Protein science : a publication of the Protein Society 33 (6) (2024)
Cheng-Chiao Huang, Chia-Ming Hsu, Min-Wu Chao, Kai-Cheng Hsu, Tony Eight Lin, Shih-Chung Yen, Huang-Ju Tu, Shiow-Lin Pan
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer. Protein science : a publication of the Protein Society 33 (6) (2024)
Tony Eight Lin, Dyan Yen, Wei-Chun HuangFu, Yi-Wen Wu, Jui-Yi Hsu, Shih-Chung Yen, Tzu-Ying Sung, Jui-Hua Hsieh, Shiow-Lin Pan, Chia-Ron Yang, Wei-Jan Huang, Kai-Cheng Hsu
An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors. Protein science : a publication of the Protein Society 33 (6) (2024)
Cheng-Chiao Huang, Chia-Ming Hsu, Min-Wu Chao, Kai-Cheng Hsu, Tony Eight Lin, Shih-Chung Yen, Huang-Ju Tu, Shiow-Lin Pan
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancer. Protein science : a publication of the Protein Society 33 (6) (2024)
Chao-Di Chang, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting Liu, Huang-Ju Tu, Ssu-Ting Lien, Tony Eight Lin, Tzu-Ying Sung, Shih-Chung Yen, Sing-Han Huang, Kai-Cheng Hsu, Shiow-Lin Pan
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Chao-Di Chang, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting Liu, Huang-Ju Tu, Ssu-Ting Lien, Tony Eight Lin, Tzu-Ying Sung, Shih-Chung Yen, Sing-Han Huang, Kai-Cheng Hsu, Shiow-Lin Pan
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Chao-Di Chang, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting Liu, Huang-Ju Tu, Ssu-Ting Lien, Tony Eight Lin, Tzu-Ying Sung, Shih-Chung Yen, Sing-Han Huang, Kai-Cheng Hsu, Shiow-Lin Pan
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Chao-Di Chang, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting Liu, Huang-Ju Tu, Ssu-Ting Lien, Tony Eight Lin, Tzu-Ying Sung, Shih-Chung Yen, Sing-Han Huang, Kai-Cheng Hsu, Shiow-Lin Pan
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Yi-Wen Wu, Min-Wu Chao, Huang-Ju Tu, Liang-Chieh Chen, Kai-Cheng Hsu, Jing-Ping Liou, Chia-Ron Yang, Shih-Chung Yen, Wei-Chun HuangFu, Shiow-Lin Pan
A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo. Oncogenesis 10 (5) (2021)
Ting-Yi Sung, Han-Li Huang, Chun-Chun Cheng, Fu-Ling Chang, Po-Li Wei, Ya-Wen Cheng, Cheng-Chiao Huang, Yu-Ching Lee, Wei-Chun HuangFu, Shiow-Lin Pan
EGFL6 promotes colorectal cancer cell growth and mobility and the anti-cancer property of anti-EGFL6 antibody. Cell & bioscience 11 (1) (2021)
Fu-Ling Chang, Keng-Chang Tsai, Tsai-Yu Lin, Tz-Wen Yang, Yan-Ni Lo, Wang-Chuan Chen, Jui-Hsien Chang, Mei-Kuang Lu, Chun-Tang Chiou, Po-Hung Chen, Yun Yen, Shiow-Lin Pan, Yu-Ching Lee
Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors. BioMed research international 2020 (2020)

Shiow-Lin Pan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shiow-Lin Pan